Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
  1. 4 Open-market buy SVP - CORP. DEV. & STRATEGY bought 10,000 shares at an average $27.51 ($275,087)
  2. 4 Grant or award Director acquired 13,346 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy HEAD OF R&D, COO-NOVITIUM OPS bought 10,000 shares at $27.65 ($276,503)
  5. 4 Shares withheld for taxes HEAD OF RARE DISEASE gave up 1,184 shares (to pay taxes)
  6. 4 Shares withheld for taxes SVP, GENERICS gave up 1,167 shares (to pay taxes)
  7. 5 Insider Annual Insider Trading Report
  8. 4 Open-market buy Director bought 1,072 shares at $46.47 ($49,820)
  9. 4 Open-market buy Director bought 3,000 shares at $42.26 ($126,794)
  10. 4 Open-market buy Director bought 2,500 shares at $39.38 ($98,450)
  11. 4 Grant or award HEAD OF R&D, COO-NOVITIUM OPS acquired 1,346,080 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Grant or award SVP - CORP. DEV. & STRATEGY acquired 383,226 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Shares withheld for taxes PRESIDENT & CEO gave up 2,577 shares (to pay taxes)
  16. 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 1,878 shares (to pay taxes)
  17. 4 Shares withheld for taxes SENIOR VICE PRESIDENT AND CFO gave up 3,042 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 337 shares (to pay taxes)
  19. 4 Shares withheld for taxes SENIOR VICE PRESIDENT AND CFO gave up 612 shares (to pay taxes)
  20. 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 802 shares (to pay taxes)

Page 17 of 42 · 835 filings